Literature DB >> 30123989

Autopsy-proven case of paraneoplastic lower motor neuron disease with sensorimotor neuropathy due to Waldenström's macroglobulinemia.

Yasuhiro Suzuki1,2, Hitoshi Aizawa3, Kento Sakashita1, Hideaki Kishi1, Kenta Nomura1, Kosuke Yoshida1, Yoko Aburakawa1, Kenji Kuroda1, Chisato Murakami2, Yasutaka Kakinoki4, Takashi Kimura1.   

Abstract

We report a case of a male patient with a 19-year history of monoclonal and later polyclonal gammopathy who subsequently developed tetraparesis, bulbar palsy, and respiratory failure. Autopsy findings showed degeneration of the hypoglossal nuclei, prominent neuronal loss and atrophy in the anterior horn of the whole spinal cord despite the presence of mild astrocytosis, degeneration of the gracilis on one side, and infiltration of inflammatory cells, which included B cells and plasma cells in the anterior and posterior roots of the lumbar spinal cord, iliopsoas muscle, and perivascular area of the cervical cord. On immunostaining, cytoplasmic inclusions of phosphorylated transactivation response DNA-binding protein of 43 kDa were observed in the motor neurons and astrocytes of the hypoglossal nuclei and whole spinal cord. The final diagnosis was paraneoplastic lower motor neuron disease with sensorimotor neuropathy due to Waldenström's macroglobulinemia.
© 2018 The Authors. Neuropathology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Neuropathology.

Entities:  

Keywords:  TDP-43; Waldenström's macroglobulinemia; anti-CD20 antibody; autopsy; paraneoplastic lower motor neuron disease

Mesh:

Year:  2018        PMID: 30123989     DOI: 10.1111/neup.12506

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  1 in total

1.  Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient.

Authors:  Sahara J Cathcart; Ericka P Greene; Suzanne Z Powell; Anithachristy S Arumanayagam; Andreana L Rivera; Rabi Tawil; Stanley H Appel; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2020-10-01       Impact factor: 3.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.